Title : FK506 Attenuates the MRP1-Mediated Chemoresistant Phenotype in Glioblastoma Stem-Like Cells.

Pub. Date : 2018 Sep 11

PMID : 30208561






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 FK506 Attenuates the MRP1-Mediated Chemoresistant Phenotype in Glioblastoma Stem-Like Cells. Tacrolimus ATP binding cassette subfamily C member 1 Homo sapiens
2 Tacrolimus (FK506) has been identified as an MRP1 regulator in differentiated glioblastoma (GBM) cells (non-GSCs); however, the effect of FK506 on GSCs is currently unknown. Tacrolimus ATP binding cassette subfamily C member 1 Homo sapiens
3 Tacrolimus (FK506) has been identified as an MRP1 regulator in differentiated glioblastoma (GBM) cells (non-GSCs); however, the effect of FK506 on GSCs is currently unknown. Tacrolimus ATP binding cassette subfamily C member 1 Homo sapiens
4 The objective of the following research is to evaluate the effect of FK506 on the MRP1-related chemo-resistant phenotype of GSCs. Tacrolimus ATP binding cassette subfamily C member 1 Homo sapiens
5 We conclude that FK506 confers a chemo-sensitive phenotype to MRP1-drug substrate in GSCs. Tacrolimus ATP binding cassette subfamily C member 1 Homo sapiens